We are live on ! Find out more
PLRX icon

Pliant Therapeutics
PLRX

143 hedge funds and large institutions have $687M invested in Pliant Therapeutics in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 50 increasing their positions, 33 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 33

47% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 19

11% more call options, than puts

Call options by funds: $3.75M | Put options by funds: $3.37M

6% more funds holding

Funds holding: 135 → 143 (+8)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

2.3% less ownership

Funds ownership: 108.21% → 105.91% (-2.3%)

29% less capital invested

Capital invested by funds: $971M → $687M (-$284M)

Holders
143
Holders Change
+8
Holders Change %
+5.93%
% of All Funds
2.07%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
28
Increased
50
Reduced
33
Closed
19
Calls
$3.75M
Puts
$3.37M
Net Calls
+$373K
Net Calls Change
+$1.08M

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$10.1M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$8.29M
3
BlackRock
BlackRock
New York
+$4.08M
4
Morgan Stanley
Morgan Stanley
New York
+$3.74M
5
CS
Candriam SCA
Luxembourg
+$3.68M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$16.4M
2
Capital International Investors
Capital International Investors
California
-$14.9M
3
LCM
Laurion Capital Management
New York
-$12.6M
4
Franklin Resources
Franklin Resources
California
-$6.6M
5
Ameriprise
Ameriprise
Minnesota
-$5.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
TD Asset Management
51
TD Asset Management
Ontario, Canada
$1.21M – – –
WP
52
Woodline Partners
California
$1.11M +$44.9K +3,480 +3%
BDFN
53
Bond & Devick Financial Network
Minnesota
$1.08M – – –
Hudson Bay Capital Management
54
Hudson Bay Capital Management
Connecticut
$1.07M +$394K +30,600 +44%
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
$1.04M +$189K +14,662 +18%
ECM
56
ExodusPoint Capital Management
New York
$1M +$202K +15,668 +20%
Swiss National Bank
57
Swiss National Bank
Switzerland
$950K – – –
Manulife (Manufacturers Life Insurance)
58
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$897K +$15.4K +1,191 +1%
Squarepoint
59
Squarepoint
New York
$865K +$1.04M +80,475 New
Wells Fargo
60
Wells Fargo
California
$862K +$114K +8,876 +12%
UOC
61
UBS O'Connor
Illinois
$828K +$993K +77,000 New
American Century Companies
62
American Century Companies
Missouri
$797K +$146K +11,351 +18%
Millennium Management
63
Millennium Management
New York
$788K +$551K +42,751 +140%
AG
64
Algert Global
California
$751K +$682K +52,912 +313%
HWAM
65
Hennion & Walsh Asset Management
New Jersey
$734K +$880K +68,289 New
HWM
66
HighMark Wealth Management
Minnesota
$726K +$322K +25,000 +59%
Skandinaviska Enskilda Banken (SEB)
67
Skandinaviska Enskilda Banken (SEB)
Sweden
$704K – – –
PP
68
PDT Partners
New York
$681K +$817K +63,352 New
AllianceBernstein
69
AllianceBernstein
Tennessee
$635K – – –
Verition Fund Management
70
Verition Fund Management
Connecticut
$607K +$728K +56,501 New
State of Wisconsin Investment Board
71
State of Wisconsin Investment Board
Wisconsin
$584K +$354K +27,471 +102%
Royal Bank of Canada
72
Royal Bank of Canada
Ontario, Canada
$560K +$61K +4,734 +10%
AGP
73
Artia Global Partners
Florida
$538K -$645K -50,000 -50%
HP
74
Harbourvest Partners
Massachusetts
$531K – – –
JP Morgan Chase
75
JP Morgan Chase
New York
$529K -$118K -9,138 -16%
1 2
3
4 5

PLRX Hedge Fund Activity: Q2 2024 in Review

143 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Pliant Therapeutics (PLRX) for Q2 2024, worth a combined $687M — down 29% from $971M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new PLRX positions and 19 closed out — a net gain of 9 holders — while 50 added to existing stakes and 33 trimmed.

The largest buyer was Great Point Partners, adding an estimated $10.1M. The largest seller was Citadel Advisors, cutting an estimated $16.4M.

  • 143 institutional investors held Pliant Therapeutics (PLRX) as of Q2 2024, up from 135 in Q1 2024.
  • Funds reported $687M of Pliant Therapeutics stock for Q2 2024, down 29% quarter-over-quarter.
  • 28 funds opened new Pliant Therapeutics positions in Q2 2024 and 19 closed out, a net change of +9 holders.
  • The largest Pliant Therapeutics buyer in Q2 2024 was Great Point Partners, an estimated $10.1M added.
  • The largest Pliant Therapeutics seller in Q2 2024 was Citadel Advisors, an estimated $16.4M sold.

Based on aggregated 13F filings for Q2 2024.